A standard approach in QT measurement improves communication between clinicians
An abnormally prolonged QT interval is associated with an increased risk of sudden cardiac death.1 Some professional bodies recommend national population-based screening programs to detect QT prolongation.2 Familial long QT syndrome (LQTS) may remain undetected because of misdiagnosis (eg, as a seizure disorder)3 or through failure to measure the QT interval correctly.4 Psychiatrists fear the QT prolongation caused by many psychotropic medications,5 and it may also be seen during periods of hypothermia; electrolyte imbalance (such as hypokalaemia, hypomagnesaemia and hypocalcaemia); in the setting of raised intracranial pressure or post-cardiac arrest; with other medications, such as type 1A, 1C and III antiarrhythmic agents; and with antihistamines and macrolide antibiotics.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Jon Skinner has no relevant disclosures. Kathryn Waddell-Smith is supported by grants from the Green Lane Research and Educational Fund and the National Heart Foundation, New Zealand.